Orchestra BioMed Holdings (OBIO) Other Gross PP&E Adjustments (2022 - 2026)

Orchestra BioMed Holdings (OBIO) reported Other Gross PP&E Adjustments of $2.2 million for Q1 2026, up 164.77% year-over-year from $843000.0 in Q1 2025, and up 20.65% on a QoQ basis from $1.8 million in Q4 2025.

Orchestra BioMed Holdings (OBIO) has 5 years of Other Gross PP&E Adjustments data on file, last reported at $2.2 million in Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 164.77% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 164.77% YoY) and the FY2025 annual result came in at $1.8 million, up 216.78% from the prior year.
  • Other Gross PP&E Adjustments advanced to $2.2 million in Q1 2026 per OBIO's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.2 million in Q1 2026 and bottomed at -$1.6 million in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $805500.0 (2023), against an average of $774357.1.
  • Peak annual rise in Other Gross PP&E Adjustments reached 1034.04% in 2024, while the deepest fall reached 23.96% in 2024.
  • Tracing OBIO's Other Gross PP&E Adjustments over 5 years: stood at -$1.6 million in 2022, then jumped by 147.06% to $768000.0 in 2023, then slipped by 23.96% to $584000.0 in 2024, then surged by 216.78% to $1.8 million in 2025, then increased by 20.65% to $2.2 million in 2026.
  • Per Business Quant, the three latest OBIO Other Gross PP&E Adjustments figures stand at $2.2 million (Q1 2026), $1.8 million (Q4 2025), and $1.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -60,691.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -892,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -189.30 Mn
10 Orchestra BioMed Holdings 245.24 Mn 255.02 Mn 78,000.00 2.23 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.23 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 1.85 Mn
Dec 31, 2025 1.85 Mn
Sep 30, 2025 1.49 Mn
Sep 30, 2025 1.49 Mn
Jun 30, 2025 1.03 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 843,000.00
Mar 31, 2025 843,000.00
Dec 31, 2024 584,000.00
Dec 31, 2024 584,000.00
Sep 30, 2024 759,000.00
Sep 30, 2024 759,000.00
Jun 30, 2024 1.05 Mn
Jun 30, 2024 1.05 Mn
Mar 31, 2024 878,000.00
Mar 31, 2024 878,000.00
Dec 31, 2023 768,000.00
Dec 31, 2023 768,000.00
Sep 30, 2023 634,000.00
Sep 30, 2023 634,000.00
Jun 30, 2023 454,000.00
Jun 30, 2023 454,000.00
Mar 31, 2023 -94,000.00
Mar 31, 2023 -94,000.00
Dec 31, 2022 -1.63 Mn
Dec 31, 2022 -1.63 Mn